查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1701394

基因静默市场规模、份额、趋势分析报告：按应用、产品/服务、最终用途、地区、细分市场预测，2025-2030

Gene Silencing Market Size, Share & Trends Analysis Report By Application (Drug Discovery & Development, Therapeutics Manufacturing), By Product & Service, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

基因静默市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球基因静默市场规模预计到2030年将达到212.9亿美元，2025年至2030年的复合年增长率为13.8%。

由于人们对遗传疾病的认识不断提高以及治疗方法，市场正在经历显着增长。近年来， RNA干扰（RNAi）、反义寡核苷酸（ASO）和基于CRISPR的方法等基因静默技术的进步，为治疗以前无法治癒的遗传疾病带来了突破。随着研究的进展，製药和生物技术公司正在投入大量资源开发基因静默疗法，以满足患有亨廷顿氏舞蹈症、肌肉萎缩症和罕见癌症等遗传疾病的患者未满足的医疗需求。对此类创新标靶治疗药物的需求不断增长是市场的主要驱动力。

COVID-19 疫情为许多方面带来了破坏性影响，但也凸显了基因治疗的重要性，并加速了基因静默技术的发展。疫情期间，研究机构和製药公司之间资金投入和合作的增加，活性化了疫苗技术的快速发展，并凸显了基因静默策略在治疗多种疾病的潜力。此外，疫情也增加了人们对基因研究和药物发现创新的关注，刺激了病毒感染、癌症治疗和自体免疫疾病等领域对基因静默方案的需求。因此，基因静默技术受到关注，并定位为未来精准医疗的重要组成部分。

此外，基因静默相关服务的日益普及也推动了市场扩张。受託研究机构（CRO）和契约製造组织（CMO）已成为生物技术和製药公司开发基因静默疗法的重要合作伙伴。这些服务供应商提供临床试验、法规遵循和可扩展製造方面的专业知识，使基于基因静默的药物开发更快、更具成本效益。这场大流行凸显了对强大、可扩展生产系统的需求，进一步推动了对支持基因治疗开发的服务的需求。随着基因静默产品线的扩大以及公司努力满足对这些先进治疗方案日益增长的需求，预计这一趋势将持续下去。

基因静默市场报告重点

  • 根据产品/服务，预计服务成长最快，预测期内复合年增长率为 14.2%。基因静默技术的复杂性增加了对临床试验管理、监管指导和生物资讯分析方面专家支持的需求。对此类客製化解决方案和端到端服务的需求不断增长，推动了市场的扩张。
  • 根据应用，药物发现和开发领域占据了市场主导地位，在 2024 年占据了最大的收入份额。高通量筛检、生物资讯学工具和基因组资料库的进步有望增强目标识别和检验过程，从而推动全球市场的成长。
  • 根据最终用途，製药和生物技术公司将主导市场，占据 2024 年最大的收益占有率。这个市场受到对精准医疗日益增长的关注以及基因治疗方法在治疗多种遗传疾病、癌症和罕见疾病方面的潜力的推动。
  • 2024 年，北美占最大份额，为 48.23%。该地区人口极易患罕见疾病，市场渗透率不断提高，医疗保健基础设施技术先进，这些因素支持该地区的成长。
  • 一些主要的市场参与者包括 Revvity, Inc.、Danaher、Agilent Technologies、GenScript、Merck KGaA、Thermo Fisher Scientific, Inc.、Illumina、Bio-Rad Laboratories、Bio-Techne 和 New England Biolabs, Inc.

目录

第一章调查方法与范围

第二章执行摘要

第三章基因静默市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 基因静默市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19影响分析

第四章基因静默市场：依产品和服务的估计和趋势分析

  • 产品/服务细分仪表板
  • 全球基因静默市场（按产品和服务）波动分析
  • 全球基因静默市场规模及趋势分析（依产品/服务，2018-2030）
  • 产品
    • RNAi
    • CRISPR-Cas9
    • 反义寡核苷酸
    • 其他的
  • 服务

第五章基因静默市场：按应用的估计和趋势分析

  • 应用程式细分仪表板
  • 全球基因静默市场趋势分析（按应用）
  • 全球基因静默市场规模及趋势分析（依应用，2018-2030）
  • 药物研发
    • 神经病学
    • 肿瘤学
    • 感染疾病
    • 代谢紊乱
    • 其他的
  • 药品製造
  • 农业用途
  • 其他的

第六章基因静默市场：依最终用途的估计和趋势分析

  • 最终用途细分仪表板
  • 全球基因静默市场趋势分析（依最终用途）
  • 全球基因静默市场规模及趋势分析（依最终用途划分）（2018-2030）
  • 製药和生物技术公司
  • 学术研究所
  • CRO 和 CMO
  • 其他的

第七章基因静默市场：区域应用评估与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域使用市场仪表板
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争格局

  • 参与企业
  • 2024年企业市场分析
  • 战略地图
  • 参与企业概况及简介
    • Revvity, Inc.
    • Danaher
    • Agilent Technologies
    • GenScript
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Illumina
    • Bio-Rad Laboratories
    • Bio-Techne
    • New England Biolabs, Inc.
Product Code: GVR-4-68040-544-0

Gene Silencing Market Growth & Trends:

The global gene silencing market size is expected to reach USD 21.29 billion by 2030 and is expected to grow at 13.8% CAGR from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing significant growth due to increasing recognition of genetic disorders and urgent need for effective therapies. Over the past few years, advancements in gene silencing technologies, including RNA interference (RNAi), antisense oligonucleotides (ASOs), and CRISPR-based approaches, have led to breakthroughs in treating previously untreatable genetic diseases. As research intensifies, pharmaceutical and biotechnology companies are allocating more resources to developing gene silencing therapies to address the unmet medical needs of patients suffering from genetic conditions such as Huntington's disease, muscular dystrophy, and rare cancers. This growing demand for innovative, targeted therapies is a key driver for the market.

The COVID-19 pandemic, while disruptive in many areas, also highlighted the importance of gene-based therapies and accelerated the development of gene silencing technologies. During the pandemic, increased funding and collaboration between research institutions and pharmaceutical companies led to the rapid development of vaccine technologies, highlighting the potential of gene silencing strategies for tackling a wide range of diseases. In addition, the pandemic led to a greater focus on genetic research and innovation in drug discovery, driving the need for gene silencing solutions in areas such as viral infections, cancer treatment, and autoimmune disorders. As a result, gene silencing technologies have garnered more attention, positioning them as a critical component in the future of precision medicine.

Furthermore, the growing availability of gene silencing-related services has fueled market expansion. Contract research organizations (CROs) and contract manufacturing organizations (CMOs) have become integral partners for biotech and pharmaceutical companies developing gene silencing therapies. These service providers offer expertise in clinical trials, regulatory compliance, and scalable manufacturing, enabling faster and more cost-effective development of gene silencing-based drugs. The pandemic underscored the need for robust and scalable production systems, driving further demand for services that support gene therapy development. This trend is expected to continue as the pipeline for gene silencing products expands and as companies work to meet the increasing demand for these advanced therapeutic options.

Gene Silencing Market Report Highlights:

  • By product & service, services is expected to witness the fastest growth with a CAGR of 14.2% during the forecast period. The complexity of gene silencing techniques has created a need for expert support in clinical trial management, regulatory guidance, and bioinformatics analysis. This rising demand for customized solutions and end-to-end services is fueling market expansion
  • By application, the drug discovery & development segment dominated the market and captured the largest revenue share in 2024. Advances in high-throughput screening, bioinformatics tools, and genomic databases have enhanced target identification and validation processes and are expected to fuel global market growth
  • By end use, the pharmaceutical & biotechnology companies segment dominated the market and accounted for the largest revenue share in 2024. The market is driven by the increasing focus on precision medicine and the potential of gene-based therapies to treat a wide range of genetic disorders, cancers, and rare diseases
  • North America held the largest share of 48.23% in 2024. The presence of a population with high susceptibility to rare diseases, increased market penetration rates, and technologically advanced healthcare infrastructure support the region's growth
  • A few of the key market players include Revvity, Inc., Danaher, Agilent Technologies, GenScript, Merck KGaA, Thermo Fisher Scientific, Inc., Illumina, Bio-Rad Laboratories, Bio-Techne, New England Biolabs, Inc.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product & Service
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Gene Silencing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising Prevalence of Genetic Disorders
      • 3.2.1.2. Technological Advancements in Delivery Systems
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Development Costs and Complex Manufacturing
      • 3.2.2.2. Regulatory and Ethical Challenges
  • 3.3. Gene Silencing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Gene Silencing Market: Product & Service Estimates & Trend Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. Global Gene Silencing Market Product & Service Movement Analysis
  • 4.3. Global Gene Silencing Market Size & Trend Analysis, by Product & Service, 2018 - 2030 (USD Million)
  • 4.4. Products
  • 4.5. Products Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
    • 4.5.1. RNAi
      • 4.5.1.1. RNAi Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.5.1.2. miRNA
        • 4.5.1.2.1. miRNA Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.5.1.3. siRNA
        • 4.5.1.3.1. siRNA Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.5.1.4. Others
      • 4.5.1.5. Others Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.5.2. CRISPR-Cas9
      • 4.5.2.1. CRISPR-Cas9 Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.5.2.2. CRISPR Kits & Reagents
        • 4.5.2.2.1. CRISPR Kits & Reagents Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.5.2.3. CRISPR Libraries
        • 4.5.2.3.1. CRISPR Libraries Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.5.2.4. Others
      • 4.5.2.5. Others Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.5.3. Antisense Oligonucleotides
      • 4.5.3.1. Antisense Oligonucleotides Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Others Market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)

Chapter 5. Gene Silencing Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Gene Silencing Market Application Movement Analysis
  • 5.3. Global Gene Silencing Market Size & Trend Analysis, by Application, 2018 - 2030 (USD Million)
  • 5.4. Drug Discovery & Development
  • 5.5. Drug Discovery & Development Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
    • 5.5.1. Neurology
      • 5.5.1.1. Neurology Market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.5.2. Oncology
      • 5.5.2.1. Oncology Market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.5.3. Infectious Diseases
      • 5.5.3.1. Infectious Diseases Market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.5.4. Metabolic Diseases
      • 5.5.4.1. Metabolic Diseases Market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.5.5. Others
      • 5.5.5.1. Others Market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.6. Therapeutics Manufacturing
    • 5.6.1. Therapeutics Manufacturing Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
  • 5.7. Agricultural Applications
    • 5.7.1. Agricultural Applications Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)

Chapter 6. Gene Silencing Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global Gene Silencing Market End Use Movement Analysis
  • 6.3. Global Gene Silencing Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & Biotechnology Companies Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & Research Institutes Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
  • 6.6. CROs & CMOs
    • 6.6.1. CROs & CMOs Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)

Chapter 7. Gene Silencing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Strategy Mapping
  • 8.4. Participants Overview
    • 8.4.1. Revvity, Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Danaher
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Agilent Technologies
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. GenScript
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Merck KGaA
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Thermo Fisher Scientific, Inc.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Illumina
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Bio-Rad Laboratories
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Bio-Techne
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. New England Biolabs, Inc.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Gene Silencing Market, by Region, 2018 - 2030 (USD Million)
  • Table 3 North America Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 4 North America Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 5 North America Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 7 U.S. Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 8 U.S. Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 9 Canada Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 10 Canada Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 Canada Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 12 Mexico Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 13 Mexico Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 14 Mexico Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 15 Europe Gene Silencing Market, by Region, 2018 - 2030 (USD Million)
  • Table 16 Europe Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 17 Europe Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 18 Europe Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 19 UK Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 20 UK Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 21 UK Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 22 Germany Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 23 Germany Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 Germany Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Italy Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 26 Italy Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 27 Italy Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 28 France Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 29 France Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 30 France Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 31 Spain Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 32 Spain Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 Spain Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 34 Sweden Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 35 Sweden Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 36 Sweden Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 37 Denmark Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 38 Denmark Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 39 Denmark Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 40 Norway Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 41 Norway Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 42 Norway Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Gene Silencing Market, by Region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 47 China Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 48 China Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 China Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 50 Japan Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 51 Japan Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 Japan Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 53 India Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 54 India Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 55 India Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 56 South Korea Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 57 South Korea Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 58 South Korea Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 59 Australia Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 60 Australia Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 61 Australia Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Thailand Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 63 Thailand Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 64 Thailand Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 65 Latin America Gene Silencing Market, by Region, 2018 - 2030 (USD Million)
  • Table 66 Latin America Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 67 Latin America Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 68 Latin America Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 69 Brazil Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 70 Brazil Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 71 Brazil Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 72 Argentina Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 73 Argentina Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 74 Argentina Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 75 Middle East Africa Gene Silencing Market, by Region, 2018 - 2030 (USD Million)
  • Table 76 Middle East Africa Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 77 Middle East Africa Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 78 Middle East Africa Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 South Africa Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 80 South Africa Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 South Africa Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 85 UAE Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 86 UAE Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 87 UAE Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value-Chain-Based Sizing & Forecasting
  • Fig. 6 QFD Modeling for Market Share Assessment
  • Fig. 7 Market formulation & Validation
  • Fig. 8 Gene Silencing Market: Market Outlook
  • Fig. 9 Parent Market Outlook
  • Fig. 10 Related/Ancillary Market Outlook
  • Fig. 11 Penetration and Growth Prospect Mapping
  • Fig. 12 Industry Value Chain Analysis
  • Fig. 13 Gene Silencing Market Driver Impact
  • Fig. 14 Gene Silencing Market Restraint Impact
  • Fig. 15 Gene Silencing Market Strategic Initiatives Analysis
  • Fig. 16 Gene Silencing Market: Product & Service Movement Analysis
  • Fig. 17 Gene Silencing Market: Product & Service Outlook and Key Takeaways
  • Fig. 18 Products Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 19 RNAi Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 20 miRNA Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 21 siRNA Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 23 CRISPR-Cas9 Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 24 CRISPR Kits & Reagents Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 25 CRISPR Libraries Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Others Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Antisense Oligonucleotides Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Others Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Services Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Gene Silencing Market: Application Movement Analysis
  • Fig. 31 Gene Silencing Market: Application Outlook and Key Takeaways
  • Fig. 32 Drug Discovery & Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Neurology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Infectious Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Metabolic Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Therapeutics Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Agricultural Applications Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Gene Silencing Market: End-Use Movement Analysis
  • Fig. 42 Gene Silencing Market: End-Use Outlook and Key Takeaways
  • Fig. 43 Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 CROs & CMOs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Global Gene Silencing Market: Regional Movement Analysis
  • Fig. 48 Global Gene Silencing Market: Regional Outlook and Key Takeaways
  • Fig. 49 North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 U.S. Country Dynamics
  • Fig. 51 U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Canada Country Dynamics
  • Fig. 53 Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico Country Dynamics
  • Fig. 55 Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 UK Country Dynamics
  • Fig. 58 UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Germany Country Dynamics
  • Fig. 60 Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 France Country Dynamics
  • Fig. 62 France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Italy Country Dynamics
  • Fig. 64 Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Spain Country Dynamics
  • Fig. 66 Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Denmark Country Dynamics
  • Fig. 68 Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Sweden Country Dynamics
  • Fig. 70 Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Norway Country Dynamics
  • Fig. 72 Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 China Country Dynamics
  • Fig. 75 China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Japan Country Dynamics
  • Fig. 77 Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 India Country Dynamics
  • Fig. 79 India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Thailand Country Dynamics
  • Fig. 81 Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 South Korea Country Dynamics
  • Fig. 83 South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Australia Country Dynamics
  • Fig. 85 Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Brazil Country Dynamics
  • Fig. 88 Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Argentina Country Dynamics
  • Fig. 90 Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 South Africa Country Dynamics
  • Fig. 93 South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Saudi Arabia Country Dynamics
  • Fig. 95 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 UAE Country Dynamics
  • Fig. 97 UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Kuwait Country Dynamics
  • Fig. 99 Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Market Position of Key Market Players